文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血急性期尼古丁替代治疗

Nicotine replacement therapy during the acute phase of aneurysmal subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2025-10-24

该回顾性研究基于前瞻性质量登记数据,纳入495例aSAH患者,其中220例接受尼古丁替代治疗(NRT)。NRT未预测影像学/超声血管痉挛或DCI相关梗死,未增加并发症;但轻度吸烟者接受NRT后不良结局更常见且住院更长,中重度吸烟者接受NRT后房颤更少且ICU停留更短。

要点

  • NRT未增加aSAH后血管痉挛、DCI相关梗死或常见并发症风险。
  • 轻度吸烟者(≤10支/日)使用NRT与不良结局增加和住院延长相关。
  • 中重度吸烟者(>10支/日)使用NRT与房颤减少和ICU停留缩短相关。

核心结论

  • NRT对aSAH后血管痉挛或DCI相关梗死无影响,且未增加并发症频率。
  • 轻度吸烟者似乎宜避免使用NRT。

研究设计与样本

  • 回顾性研究,使用前瞻性质量登记的匿名数据,共纳入495例aSAH患者,其中220例接受NRT。
  • 吸烟者分为非NRT组和NRT组,并细分为轻度吸烟者(≤10支/日)和中重度吸烟者(>10支/日)。

主要发现

  • NRT不是影像学/超声血管痉挛或DCI相关梗死的预测因素。
  • 轻度吸烟者接受NRT时不良结局更频繁(12.49% vs 29.31%)且住院时间更长。
  • 中重度吸烟者接受NRT时房颤更少(3.4% vs 11.7%)且ICU停留时间更短。
  • 两组间血栓栓塞事件、癫痫事件或呼吸衰竭无差异。
  • 90天戒烟率在有或无NRT时无差异。

关键数值与推荐

  • 轻度吸烟者定义为≤10支/日,中重度吸烟者定义为>10支/日。
  • 结局指标包括90天死亡率、改良Rankin量表(mRS)评分、影像学/超声及临床血管痉挛、DCI相关梗死等并发症。

临床怎么用

  • 对aSAH后轻度吸烟者(≤10支/日)应避免使用NRT。
  • 对中重度吸烟者使用NRT可能减少房颤并缩短ICU停留,但需结合个体情况权衡。

局限性

  • 回顾性研究设计,使用登记数据,可能存在选择偏倚和混杂。
  • 摘要未报告多变量校正结果及具体P值,因果推断受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients who suffer an aneurysmal subarachnoid hemorrhage (aSAH) are active smokers that may experience nicotine withdrawal following hospital admission. Nicotine replacement therapy (NRT) could alleviate abstinence and delirium but may have unwanted side-effects. Cerebral vasospasm (VS) is a feared complication of aSAH that can worsen outcome. The impact of NRT on VS, complications and outcome is still not fully delineated. METHODS: Retrospective study using anonymized data from a prospective quality registry. Patients smoking status, age, sex, comorbidities, along with aSAH severity were registered. Smokers were dichotomized into non-NRT and NRT groups depending on whether they had received a nicotine patch or not and subdivided into light smokers (≤ 10 cigarettes/day) and moderate to heavy smokers (> 10 cigarettes/day). We also registered radiological/sonological and clinical VS, delayed cerebral ischemia (DCI) related infarction and other common aSAH complications. Outcome was scored in terms of mortality and modified Rankin Score (mRS) at 90 days. RESULTS: 495 patients were included; 220 received NRT. NRT was not a predictor of radiological/ultrasonological VS or DCI-related infarction. Poor outcome was more frequent in light smokers when they had received NRT (12.49% vs 29.31%) and their length of hospitalization was longer. Moderate to heavy smokers that had received NRT developed less frequently atrial fibrillation (3.4% vs 11.7%) and their length of stay at the ICU was shorter. There was no difference in thromboembolic or epileptic events, or respiratory failure between groups. There was no difference in smoking cessation at 90 days with or without NRT. CONCLUSIONS: NRT had no impact on vasospasm or DCI-related infarction and it did not increase the frequency of complications. It seems advisable to abstain from NRT in light smokers.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Ghafaji H, Sorteberg A. Nicotine replacement therapy during the acute phase of aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2025. PMID: 41134380. doi:10.1007/s00701-025-06698-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。